The quantification of these results showed significantly higher levels of visfatin expression in the higher-stage tumors (IIB and IVA) than in the lower-stage tumors (IB and IIA) and normal tissue samples (Figure 1F), indicating a positive association between levels of visfatin expression and ESCC cancer progression. The gene discussed is NAMPT; the disease is cancer.